AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$2.94
+0.17 (+6.14%)
As of Feb 8, 2:11 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 23.13M 22.23M 24.20M
Net Income -3,425,590 -3,026,461 -3,348,387
EPS
Profit Margin -14.8% -13.6% -13.8%
Rev Growth +10.2% +14.5% +15.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 11.47M 13.67M 12.56M
Total Equity 34.49M 33.53M 40.20M
D/E Ratio 0.33 0.41 0.31
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -4,390,756 -4,014,681 -4,691,998
Free Cash Flow -2,646,725 -2,971,274 -2,303,520